Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3034 |
|
| Actual shortage: | 241 (8%) | |
| Anticipated shortage: | 18 (1%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2766 (91%) | |
Discontinuation Reports |
356 |
|
| To be discontinued: | 22 (6%) | |
| Discontinued: | 334 (94%) | |
| Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
30 (11%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-ALLOPURINOL | 300MG | TABLET | Resolved | 2024-03-15 | 2024-04-05 | 222458 |
| HEARTBURN CONTROL | 20MG | CAPSULE (DELAYED RELEASE) | Resolved | 2024-03-15 | 2024-04-05 | 222461 |
| APO-SUMATRIPTAN | 50MG | TABLET | Resolved | 2024-03-15 | 2024-04-19 | 222464 |
| APO PREDNISONE TAB 5MG | 5MG | TABLET | Resolved | 2024-03-15 | 2024-03-22 | 222467 |
| APO-IBUPROFEN | 400MG | TABLET | Resolved | 2024-03-15 | 2024-04-05 | 222470 |
| ANAFRANIL | 25MG | TABLET | Resolved | 2024-03-15 | 2024-03-22 | 222473 |
| APO-SERTRALINE | 25MG | CAPSULE | Resolved | 2024-03-15 | 2024-05-03 | 222481 |
| APO-LETROZOLE | 2.5MG | TABLET | Resolved | 2024-03-22 | 2024-04-12 | 223043 |
| APO-AMOXI CLAV | 125MG 875MG | TABLET | Resolved | 2024-03-22 | 2024-04-05 | 223046 |
| APO-PROPAFENONE | 150MG | TABLET | Resolved | 2024-03-22 | 2024-04-26 | 223049 |
| APO-AMOXI CLAV | 125MG 250MG | TABLET | Resolved | 2024-03-22 | 2024-04-12 | 223052 |
| APO-PRAMIPEXOLE | 1.5MG | TABLET | Resolved | 2024-03-22 | 2024-04-26 | 223055 |
| APO-MONTELUKAST | 10MG | TABLET | Resolved | 2024-03-22 | 2024-04-19 | 223058 |
| APO-ALLOPURINOL | 300MG | TABLET | Resolved | 2024-03-22 | 2024-04-05 | 223061 |
| APO-PRAVASTATIN | 40MG | TABLET | Resolved | 2024-03-22 | 2024-04-12 | 223064 |
| APO-FUROSEMIDE | 20MG | TABLET | Resolved | 2024-03-22 | 2024-04-19 | 223067 |
| APO-HYDROCHLOROTHIAZIDE | 12.5MG | TABLET | Resolved | 2024-03-22 | 2024-04-26 | 223083 |
| APO-SERTRALINE | 100MG | CAPSULE | Resolved | 2024-03-27 | 2024-04-12 | 223540 |
| APO-RISPERIDONE | 1.0MG | TABLET | Resolved | 2024-03-27 | 2024-05-03 | 223543 |
| APO-ALPRAZ | 0.5MG | TABLET | Resolved | 2024-03-27 | 2024-05-03 | 223546 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-ACEBUTOLOL | 400MG | TABLET | Discontinued | 2017-03-31 | 2018-02-05 | 4965 |
| APO-OLANZAPINE | 5.0MG | TABLET | Discontinued | 2017-03-31 | 2018-02-05 | 4968 |
| APO-SOTALOL | 160MG | TABLET | Discontinued | 2017-03-31 | 2018-02-05 | 4971 |
| APO-TERAZOSIN | 2MG | TABLET | Discontinued | 2017-03-31 | 2018-02-05 | 4974 |
| APO-DOCUSATE SODIUM | 100MG | CAPSULE | Discontinued | 2018-02-23 | 2019-03-29 | 40733 |
| DOCUSATE SODIUM CAPSULES | 100MG | CAPSULE | Discontinued | 2018-02-23 | 2018-09-15 | 40738 |
| APO-FENTANYL MATRIX | 100MCG | PATCH | Discontinued | 2018-02-23 | 2018-12-28 | 40741 |
| APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2018-02-23 | 2018-02-23 | 40757 |
| APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2018-02-23 | 2018-07-17 | 40760 |
| APO-IRBESARTAN/HCTZ | Discontinued | 2018-02-23 | 2018-07-17 | 40763 | ||
| APO-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40766 |
| APO-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40769 |
| APO-METFORMIN | 850MG | TABLET | Discontinued | 2018-02-23 | 2019-06-12 | 40778 |
| APO-METFORMIN | 500MG | TABLET | Discontinued | 2018-02-23 | 2018-11-26 | 40790 |
| APO-METFORMIN | 850MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40796 |
| APO-RABEPRAZOLE | 10MG | TABLET (ENTERIC-COATED) | Discontinued | 2018-02-23 | 2019-09-12 | 40805 |
| APO-TELMISARTAN | 40MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40811 |
| APO-TELMISARTAN | 40MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40814 |
| APO-TELMISARTAN | 80MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40817 |
| APO-TELMISARTAN | 80MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40820 |